Enduring and Stable Surface Dielectric Barrier Discharge (SDBD) Plasma Using Fluorinated Multi-Layered Polyimide

por Bian, Dongliang, Wu, Yun
Publicado 2018

Inhibition of Bcl-2 and Bcl-xL overcomes the resistance to the third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer

por Lu, Yingjie, Bian, Dongliang, Zhang, Xuelin, Zhang, Huibiao, Zhu, Zhenghong
Publicado 2021

The secondary surgery provides significant benefits to recurrent thymoma: a retrospective analysis based on Surveillance, Epidemiology and End Results database

por Bian, Dongliang, Ge, Tao, Song, Nan, Zhang, Peng, Zhang, Helin, Fei, Ke
Publicado 2019

The efficacy and safety of wedge resection for peripheral stage IA lung adenocarcinoma: a real-world study based on a single center

por Bian, Dongliang, Xiong, Yicheng, Jin, Kaiqi, Zhu, Yuming, Yu, Huansha, Dai, Jie, Jiang, Gening
Publicado 2023

The efficacy of neoadjuvant EGFR-TKI therapy combined with radical surgery for stage IIIB lung adenocarcinoma harboring EGFR mutations: A retrospective analysis based on single cen...

por Xiong, Yicheng, Bian, Dongliang, Huang, Zhida, Yu, Huansha, Huang, Jie, Zhang, Peng, He, Wenxin, Liu, Hongcheng
Publicado 2023

Thymoma size significantly affects the survival, metastasis and effectiveness of adjuvant therapies: a population based study

por Bian, Dongliang, Zhou, Feng, Yang, Weiguang, Zhang, Kaixuan, Chen, Linsong, Jiang, Gening, Zhang, Peng, Wu, Chunyan, Fei, Ke, Zhang, Lei
Publicado 2018

Efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis

por Bian, Dongliang, Jiang, Siming, Xiong, Yicheng, Qi, Mengfan, Wu, Jiawei, Addeo, Alfredo, Yamauchi, Yoshikane, Manapov, Farkhad, Dempke, Wolfram C. M., Vannucci, Jacopo, Di Federico, Alessandro, Xu, Xiaoxiong, Chen, Linsong
Publicado 2022

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

por Hu, Junjie, Zhang, Lele, Xia, Haoran, Yan, Yilv, Zhu, Xinsheng, Sun, Fenghuan, Sun, Liangdong, Li, Shuangyi, Li, Dianke, Wang, Jin, Han, Ya, Zhang, Jing, Bian, Dongliang, Yu, Huansha, Chen, Yan, Fan, Pengyu, Ma, Qiang, Jiang, Gening, Wang, Chenfei, Zhang, Peng
Publicado 2023

Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study

por Bian, Dongliang, Sun, Liangdong, Hu, Junjie, Duan, Liang, Xia, Haoran, Zhu, Xinsheng, Sun, Fenghuan, Zhang, Lele, Yu, Huansha, Xiong, Yicheng, Huang, Zhida, Zhao, Deping, Song, Nan, Yang, Jie, Bao, Xiao, Wu, Wei, Huang, Jie, He, Wenxin, Zhu, Yuming, Jiang, Gening, Zhang, Peng
Publicado 2023

Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial

por Zhu, Xinsheng, Sun, Liangdong, Song, Nan, He, Wenxin, Xie, Boxiong, Hu, Junjie, Zhang, Jing, Yang, Jie, Dai, Jie, Bian, Dongliang, Xia, Haoran, Sun, Fenghuan, Xiong, Anwen, Luo, Jie, Zhang, Lele, Yu, Huansha, Liu, Ming, Liu, Hongcheng, Wang, Haifeng, Zhang, Haiping, Chen, Chang, Wu, Chunyan, Duan, Liang, Zhu, Yuming, Zhang, Peng, Jiang, Gening
Publicado 2022